相似文献
1
Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.
Cell Biosci. 2021 Jan 6;11(1):2. doi: 10.1186/s13578-020-00504-1.
2
Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
Front Immunol. 2018 Mar 26;9:541. doi: 10.3389/fimmu.2018.00541. eCollection 2018.
3
Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice.
J Clin Epidemiol. 1995 Apr;48(4):571-82. doi: 10.1016/0895-4356(94)00215-c.
4
Implementation of the Connective Tissue Screening Questionnaire in northeast Pennsylvania to identify comorbidities of connective tissue diseases in subjects with systemic lupus erythematosus.
J Prim Care Community Health. 2014 Apr 1;5(2):134-8. doi: 10.1177/2150131913511118. Epub 2013 Nov 25.
5
Cholinergic anti-inflammatory pathway and connective tissue diseases.
Inflammopharmacology. 2021 Aug;29(4):975-986. doi: 10.1007/s10787-021-00812-z. Epub 2021 Jun 14.
6
Insights into IL-29: Emerging role in inflammatory autoimmune diseases.
J Cell Mol Med. 2019 Dec;23(12):7926-7932. doi: 10.1111/jcmm.14697. Epub 2019 Oct 2.
7
Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still's Disease, Dermatomyositis/Polymyositis, Sjögren's Syndrome, and Mixed Connective Tissue Disease.
Semin Musculoskelet Radiol. 2018 Apr;22(2):166-179. doi: 10.1055/s-0038-1639473. Epub 2018 Apr 19.
8
Thoracic manifestations of connective tissue diseases.
Curr Probl Diagn Radiol. 2015 Jan-Feb;44(1):47-59. doi: 10.1067/j.cpradiol.2014.07.002. Epub 2014 Aug 15.
9
Interleukin-13: A promising therapeutic target for autoimmune disease.
Cytokine Growth Factor Rev. 2019 Feb;45:9-23. doi: 10.1016/j.cytogfr.2018.12.001. Epub 2018 Dec 12.
10
Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment.
Open Dermatol J. 2009 Jan 1;3(1):22-31. doi: 10.2174/1874372200903010022.
引用本文的文献
1
Interleukin-22 promotes cancer stemness and chemotherapy resistance in colorectal cancer epidermal growth factor receptor/extracellular signal-regulated kinase pathway.
World J Gastrointest Oncol. 2025 Aug 15;17(8):108535. doi: 10.4251/wjgo.v17.i8.108535.
2
Gut microbiome-immune interactions and their role in rheumatoid arthritis development.
PeerJ. 2024 Jul 11;12:e17477. doi: 10.7717/peerj.17477. eCollection 2024.
3
Microbiota as key factors in inflammatory bowel disease.
Front Microbiol. 2023 Oct 13;14:1155388. doi: 10.3389/fmicb.2023.1155388. eCollection 2023.
4
Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment.
J Exp Clin Cancer Res. 2023 Jul 24;42(1):178. doi: 10.1186/s13046-023-02735-9.
5
Cellular mechanisms linking to outdoor and indoor air pollution damage during pregnancy.
Front Endocrinol (Lausanne). 2023 Feb 15;14:1084986. doi: 10.3389/fendo.2023.1084986. eCollection 2023.
6
Relationship between IL-22 and IL-22BP in diabetic cognitive dysfunction.
Acta Diabetol. 2023 May;60(5):631-644. doi: 10.1007/s00592-022-02024-5. Epub 2023 Jan 30.
7
IL-22 regulates endometrial regeneration by enhancing tight junctions and orchestrating extracellular matrix.
Front Immunol. 2022 Aug 25;13:955576. doi: 10.3389/fimmu.2022.955576. eCollection 2022.
8
Transcription Factor AhR, Cytokines IL-6 and IL-22 in Subjects with and without Peri-Implantitis: A Case Control-Study.
Int J Environ Res Public Health. 2022 Jun 17;19(12):7434. doi: 10.3390/ijerph19127434.
9
Quantitative assessment of left ventricular myocardial involvement in patients with connective tissue disease: a 3.0T contrast-enhanced cardiovascular magnetic resonance study.
Int J Cardiovasc Imaging. 2022 Jul;38(7):1545-1554. doi: 10.1007/s10554-022-02539-6. Epub 2022 Mar 13.
10
The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications.
Cells. 2021 Dec 2;10(12):3397. doi: 10.3390/cells10123397.
本文引用的文献
1
IL-22 production of effector CD4 T-cells is altered in SLE patients.
Eur J Med Res. 2019 Jul 22;24(1):24. doi: 10.1186/s40001-019-0385-6.
2
Novel paradigms in systemic lupus erythematosus.
Lancet. 2019 Jun 8;393(10188):2344-2358. doi: 10.1016/S0140-6736(19)30546-X. Epub 2019 Jun 6.
3
Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome.
Clin Exp Immunol. 2019 Nov;198(2):261-272. doi: 10.1111/cei.13337. Epub 2019 Jun 5.
4
Th22 Cells Promote Osteoclast Differentiation Production of IL-22 in Rheumatoid Arthritis.
Front Immunol. 2018 Dec 10;9:2901. doi: 10.3389/fimmu.2018.02901. eCollection 2018.
5
Role of MCP-1 and CCR2 in alcohol neurotoxicity.
Pharmacol Res. 2019 Jan;139:360-366. doi: 10.1016/j.phrs.2018.11.030. Epub 2018 Nov 22.
6
Increased interleukin-22 levels in lupus nephritis and its associated with disease severity: a study in both patients and lupus-like mice model.
Clin Exp Rheumatol. 2019 May-Jun;37(3):400-407. Epub 2018 Sep 20.
7
Impaired TGF-β signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22.
Cytokine. 2018 Aug;108:182-189. doi: 10.1016/j.cyto.2018.04.011. Epub 2018 Apr 21.
8
The role of transforming growth factor β in T helper 17 differentiation.
Immunology. 2018 Sep;155(1):24-35. doi: 10.1111/imm.12938. Epub 2018 May 8.
9
Association of interleukin 22 gene polymorphisms and serum IL-22 level with risk of systemic lupus erythematosus in a Chinese population.
Clin Exp Immunol. 2018 Aug;193(2):143-151. doi: 10.1111/cei.13133. Epub 2018 May 23.
10
Norepinephrine Inhibits Th17 Cells via β2-Adrenergic Receptor (β2-AR) Signaling in a Mouse Model of Rheumatoid Arthritis.
Med Sci Monit. 2018 Feb 27;24:1196-1204. doi: 10.12659/msm.906184.
Zotero 插件